NCT02421991 (TALK) is a NA clinical trial of Telephone Delivered Intervention in Smoking, sponsored by Fred Hutchinson Cancer Center.

Who is sponsoring NCT02421991?

NCT02421991 is sponsored by Fred Hutchinson Cancer Center.

What drugs are being tested in NCT02421991?

Interventions in NCT02421991: Telephone Delivered Intervention.

Is NCT02421991 still recruiting?

NCT02421991 is currently completed. Last updated 21 January 2020.

Last reviewed 2020-01-21 · How we verify

NCT02421991: TALK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telephone-Delivered Interventions for Smoking Cessation

Completed NA Last updated 21 January 2020

What this trial tests

NA trial testing Telephone Delivered Intervention in Smoking in 1,275 participants. Completed in 31 December 2019.

Timeline

2 November 2015

Primary endpoint
8 August 2018

31 December 2019

Quick facts

Lead sponsor	Fred Hutchinson Cancer Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	1,275
Start date	2 November 2015
Primary completion	8 August 2018
Estimated completion	31 December 2019
Sites	1 location across United States

Drugs / interventions tested

Telephone Delivered Intervention

Conditions studied

Smoking — all drugs for Smoking →

Sponsor

Fred Hutchinson Cancer Center — full company profile →

Who can join

18 and older, any sex, with Smoking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to demonstrate that Acceptance and Commitment Therapy's (ACT) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Telephone counselling for smoking cessation.
Matkin W, Ordóñez-Mena JM, Hartmann-Boyce J. · · 2019 · cited 155× · PMID 31045250 · DOI 10.1002/14651858.cd002850.pub4
Mindfulness for smoking cessation.
Jackson S, Brown J, Norris E, Livingstone-Banks J, et al · · 2022 · cited 33× · PMID 35420700 · DOI 10.1002/14651858.cd013696.pub2
Full-scale Randomized Trial Comparing Acceptance and Commitment Therapy Telephone-Delivered Coaching With Standard Telephone-Delivered Coaching Among Medicare/Uninsured Quitline Callers.
Bricker JB, Sullivan BM, Mull KE, Torres AJ, et al · · 2022 · cited 8× · PMID 35196381 · DOI 10.1093/ntr/ntac052

Verify or expand the search:

Other recruiting trials for Smoking

Currently open trials in the same condition.

NCT07488741 — Comparison of the Effects of Different Chest Techniques on University Students With Smoking Addiction · NA · recruiting
NCT07443631 — Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants · NA · recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products · NA · recruiting
NCT06966258 — Inspire HER: Inspiring the Heart and Emotions for Radical Health · NA · recruiting
NCT06713603 — Technology Assisted Motivational Interviewing · NA · recruiting

Other Fred Hutchinson Cancer Center trials

Trials by the same sponsor.

NCT07390968 — Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Pati · Phase 2 · not yet recruiting
NCT07493252 — A Behavioral Application for Improving Smoking Cessation Among Smokers · NA · not yet recruiting
NCT07490860 — A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to · NA · not yet recruiting
NCT07194980 — Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small L · Phase 2 · not yet recruiting
NCT07176000 — Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington S · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02421991 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fred Hutchinson Cancer Center
Last refreshed: 21 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02421991.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing